Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
hospimedica.com
Critical Care
Features Subscription Partner Sites Journal Info
SIEMENS HEALTHCAREUZUMCU TIBBI CIHAZ VE MED GAZSCHILLER AG

Subglottic Drainage Decreases Risk of Ventilator-Associated Pneumonia

By HospiMedica International staff writers
Posted on 14 Jul 2010


A new study has found that in patients on mechanical ventilation, intermittent subglottic secretions drainage (SSD) leads to a significant reduction in ventilator-associated pneumonia (VAP).

Researchers at André Mignot Hospital (Le Chesnay, France) and CHI Poissy Saint-Germain Hospital (Poissy, France) conducted a randomized controlled clinical trial at four French centers to determine whether SSD reduces the overall incidence of microbiologically confirmed VAP. A total of 333 adult patients intubated with a tracheal tube allowing drainage of subglottic secretions were randomly assigned to undergo intermittent SSD (169 patients) or not (164 patients). The primary outcome measure was the overall incidence of VAP, based on quantitative culture of distal pulmonary samplings performed after each clinical suspicion. Other outcomes included incidence of early- and late-onset VAP, duration of mechanical ventilation, and intensive care unit (ICU) mortality.

The results showed that microbiologically confirmed VAP was seen in 14.8% of the drainage group, compared to 25.2% of control patients. During the first 5 days, rates of pneumonia were 1.2% and 6.1%, respectively; for later onset, the corresponding rates were 18.6% and 33.0%.

There were no between-group differences in the duration of mechanical ventilation; this was also true of in-hospital ICU mortality (47.3% vs. 51.2%). The study was published ahead of print on June 3, 2010, in the American Journal of Respiratory Critical Care Medicine.

“Subglottic secretions drainage during mechanical ventilation results in a significant reduction in VAP, including late-onset VAP,” concluded lead author Jean-Claude Lacherade, M.D., of CHI Poissy Saint-Germain, and colleagues. “This should prompt physicians involved in pre-ICU care to use endotracheal tubes permitting secretion drainage.”

VAP is a costly complication of hospitalization that lengthens ICU and hospital stay, and increasing morbidity and mortality. Among evidence-based measures to prevent VAP is the use of a specialized endotracheal tube that aspirates subglottic secretions, and recommendations for SDD are found in guidelines published by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) and the American Thoracic Society (ATS), among others.

Related Links:

André Mignot Hospital
CHI Poissy Saint-Germain Hospital
U.S. Centers for Disease Control and Prevention





Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
Free digital version edition of HospiMedica International sent by email on regular basis
Free print version of HospiMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of HospiMedica International in digital format
Free HospiMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?




Ventilator
Ventilator
Blood Product Warmer
Blood Product Warmer
Infant Incubator
Infant Incubator

More Products

Latest Critical Care News

Latest Issue
View Digital Edition
Subscribe / Renew
LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured MedBiz Market Reports
Premium Report The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Premium Report Delivering Opportunities in the Inhalable Drugs Market: Innovative formulations and devices
Featured Whitepaper
Mercury Medical:
BLIND TRACHEAL INTUBATION THROUGH air-Q®

Download Whitepaper
Events
17th Symposium of the European Society of Urogenital Radiology (ESUR)
09 Sep 2010
11 Sep 2010


ILCA 2010 – 4th Annual Conference of the International Liver Cancer Association
10 Sep 2010
12 Sep 2010


17th International Symposium on Hepatitis C Virus & Related Viruses
10 Sep 2010
14 Sep 2010


More events
PACS GEAR, INC.
INTERSURGICAL
GREAT AMERICAN GROUP
Demo Company
  hospimedica.com Copyright © 2000-2010 Globetech Media. All rights reserved.